Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06UTH
|
|||
| Former ID |
DIB004090
|
|||
| Drug Name |
RDEA-684
|
|||
| Indication | Gout [ICD-11: FA25; ICD-10: M10] | Phase 2 | [1] | |
| Company |
Ardea Biosciences Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Urate anion exchanger 1 (URAT1) | Target Info | Inhibitor | [2] |
| WikiPathways | Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01927198) RDEA3170 Monotherapy in Subjects With Gout. U.S. National Institutes of Health. | |||
| REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1031). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.